Literature DB >> 29903547

Combined therapy of imatinib and an anti-CTLA4 immune-checkpoint inhibitor.

Kinam Park1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29903547     DOI： 10.1016/j.jconrel.2018.06.011

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  3 in total

Review 1.  Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.

Authors:  Quoc-Viet Le; Juhan Suh; Yu-Kyoung Oh
Journal:  AAPS J       Date:  2019-05-17       Impact factor: 4.009

Review 2.  Precise cell behaviors manipulation through light-responsive nano-regulators: recent advance and perspective.

Authors:  Do Cong Thang; Zhimin Wang; Xiaoling Lu; Bengang Xing
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

3.  Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.

Authors:  Wenquan Ou; Liyuan Jiang; Raj Kumar Thapa; Zar Chi Soe; Kishwor Poudel; Jae-Hoon Chang; Sae Kwang Ku; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Theranostics       Date:  2018-08-10       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.